Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies
Authors
Keywords
-
Journal
mAbs
Volume 2, Issue 3, Pages 233-255
Publisher
Informa UK Limited
Online
2010-06-09
DOI
10.4161/mabs.2.3.11782
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lupus-Like Syndrome Attributable to Anti—Tumor Necrosis Factor α Therapy in 14 Patients During an 8-Year Period at Mayo Clinic
- (2012) David A. Wetter et al. MAYO CLINIC PROCEEDINGS
- Investigational Immunotherapeutics for B-Cell Malignancies
- (2010) Alfonso Quintás-Cardama et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical development of monoclonal antibodies
- (2010) Kathryn Chapman et al. mAbs
- Immunotoxicity of monoclonal antibodies
- (2010) Jacques Descotes mAbs
- Practical considerations for nonclinical safety evaluation of therapeutic monoclonal antibodies
- (2010) Carmel M. Lynch et al. mAbs
- Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies
- (2009) Eugene O. Major Annual Review of Medicine
- An interspecies comparison of placental antibody transfer: New insights into developmental toxicity testing of monoclonal antibodies
- (2009) Nele Pentšuk et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
- The state of the art: immune-mediated mechanisms of monoclonal antibodies in cancer therapy
- (2009) J Griggs et al. BRITISH JOURNAL OF CANCER
- The Trifunctional Antibody Ertumaxomab Destroys Tumor Cells That Express Low Levels of Human Epidermal Growth Factor Receptor 2
- (2009) M. Jager et al. CANCER RESEARCH
- Safety Assessment and Dose Selection for First-in-Human Clinical Trials With Immunomodulatory Monoclonal Antibodies
- (2009) PY Muller et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Integrated studies of biology: multiplexed imaging assays from molecules to man and back
- (2009) Kevin W Eliceiri et al. CURRENT OPINION IN BIOTECHNOLOGY
- Novel targeted therapies for autoimmunity
- (2009) E William St Clair CURRENT OPINION IN IMMUNOLOGY
- Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-α antagonists
- (2009) John D Isaacs EXPERT OPINION ON BIOLOGICAL THERAPY
- Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment
- (2009) Rodney R. Dietert Journal of Immunotoxicology
- Monoclonal antibodies in the therapy of multiple sclerosis
- (2009) P. S. Rommer et al. JOURNAL OF NEUROLOGY
- Evaluation of the Immuno-Stimulatory Potential of Stopper Extractables and Leachables by Using Dendritic Cells as Readout
- (2009) Robert Mueller et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo
- (2009) Aran F Labrijn et al. NATURE BIOTECHNOLOGY
- Progressive Multifocal Leukoencephalopathy after Natalizumab Monotherapy
- (2009) Hans Lindå et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of High-Grade Skin Rash in Cancer Patients Treated with Cetuximab – an Antibody against Epidermal Growth Factor Receptor: Systemic Review and Meta-Analysis
- (2009) Xiao Su et al. ONCOLOGY
- Developmental toxicity testing of monoclonal antibodies: An enhanced pre- and postnatal study design option
- (2009) Jane Stewart REPRODUCTIVE TOXICOLOGY
- Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders
- (2009) Masayuki Fukata et al. SEMINARS IN IMMUNOLOGY
- Structural characterization of a human Fc fragment engineered for lack of effector functions
- (2008) Vaheh Oganesyan et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- REVIEW ARTICLE: NK Cell Tolerance and the Maternal-Fetal Interface
- (2008) Joan K. Riley et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses
- (2008) P. Bruhns et al. BLOOD
- Use of pharmacokinetic/ pharmacodynamic modelling for starting dose selection in first-in-human trials of high-risk biologics
- (2008) Balaji M. Agoram BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Trastuzumab cardiotoxicity: biological hypotheses and clinical open issues
- (2008) Emilio Bria et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Recombinant antibodies for cancer therapy
- (2008) Mahendra P Deonarain EXPERT OPINION ON BIOLOGICAL THERAPY
- Clinical immunotoxicity of therapeutic proteins
- (2008) Jacques Descotes et al. Expert Opinion on Drug Metabolism & Toxicology
- What’s So Special about the Developing Immune System?
- (2008) Leigh Ann Burns-Naas et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products
- (2008) Eugen Koren et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Testing Human Biologicals in Animal Host Resistance Models
- (2008) Gary R. Burleson et al. Journal of Immunotoxicology
- Adverse Consequences of Immunostimulation
- (2008) Rafael Ponce Journal of Immunotoxicology
- Monoclonal Antibody First Dose Cytokine Release Syndromes–Mechanisms and Prediction
- (2008) Mark Wing Journal of Immunotoxicology
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
- (2008) Christine H. Chung et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Approaches to Prediction of Immune Responses to Therapeutic Proteins during Preclinical Development
- (2008) Laura C A Perry et al. Drugs in research & development
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search